CFTR and cystic fibrosis: Given that forskolin and IBMX are not utilized for the treatment of CF in vivo either alone or in CFTR modulator combination therapies, applying these compounds acutely during electrophysiological analyses of CFTR modulator-treated cultures may result in the misestimation of modulator effectiveness.